Revenue¥195bn−0.4% year on yearConsolidated · FY12/25
Operating profit¥4.04bn−26.0% year on yearConsolidated · FY12/25
Net profit¥1.00bn−74.0% year on yearConsolidated · FY12/25
Dividend per share¥50.00FY12/25
Employees, whole group5,305 peopleFY12/25
Employees, parent company (non-consolidated)724 peopleFY12/25
Average salary¥7.42mFY12/25
Average salary is for the parent company's own employees (non-consolidated), as Japanese annual reports disclose it.
| Fiscal year | Revenue | Op. profit | Net profit (attributable) | EPS | Dividend | Total assets | Total equity | Op. cash flow |
|---|---|---|---|---|---|---|---|---|
| FY12/25 | ¥195bn−0.4% year on year | ¥4.04bn | ¥1.00bn | ¥21.13 | ¥50.00 | ¥250bn | ¥118bn | ¥9.21bn |
| FY12/24 | ¥196bn+16.6% year on year | ¥5.46bn | ¥3.85bn | ¥79.93 | ¥50.00 | ¥252bn | ¥116bn | ¥12.31bn |
| FY12/23 | ¥168bn−13.5% year on year | — | −¥2.99bn | −¥61.13 | ¥50.00 | ¥218bn | ¥111bn | ¥1.49bn |
| FY12/22 | ¥194bn+2.5% year on year | — | ¥10.14bn | ¥203.65 | ¥50.00 | ¥230bn | — | ¥12.04bn |
| FY12/21 | ¥189bn | — | ¥15.86bn | ¥318.35 | ¥40.00 | ¥209bn | — | ¥18.79bn |
Per-share figures are as each report states them: a share split is restated only for the year before it, and dividends are as paid.
Figures from annual report S100XS06 · IFRS, company-only figures: Japan GAAP. Each figure's years come from one report's five-year summary.
TSE:7915
Nissha's first-half sales beat its forecast by 2.2%, but a goodwill impairment at USM turned a guided ¥1.8bn operating profit into a ¥4.5bn loss, and the company now guides to a full-year operating loss of ¥3.3bn.
Nissha has handed over half its 60% stake in Vietnamese subsidiary USM HEALTHCARE MEDICAL DEVICES FACTORY to a company director, pulling the unit out of consolidation, while the remaining 10% stays on its books for a planned sale between 2027 and 2028, with the resulting gain or loss still under review.
Roughly three and a half months after buying a majority stake in Vietnamese device maker USM Healthcare, Nissha is selling the whole position back to USM's own director at an undisclosed price, having found circular-transaction accounting that predates the deal.
Nissha's semiannual report for the six months to June 2026, originally due August 14, now must be filed by October 23 after regulatory approval, and its second-quarter earnings summary is tied to that same later deadline.
Latest disclosed holders and exits below 5%.
| Holder | Stake | Change | Purpose | Filing |
|---|---|---|---|---|
Sumitomo Mitsui Trust Asset Management Co.,Ltd.Original (Japanese)三井住友トラスト・アセットマネジメント株式会社 | 1.45% own · 6.28% group of 2 | −1.21 pp | Asset manager / trustHeld for the purpose of management under investment trust contracts and discretionary investment contracts.Machine translatedOriginal (Japanese)投資信託契約、投資一任契約に基づく運用を目的として保有するもの。 | Filed — filing S100ZBBE |
| M&Gインベストメント・マネジメント・リミテッド | 5.33% own · 5.33% group of 2 | New | Asset manager / trustPure investment (related to the management of customer assets under a discretionary investment contract)Machine translatedOriginal (Japanese)純投資(投資一任契約に基づく顧客資産の運用に係るもの) | Filed — filing S100Z90Y |
Strategic shareholdings and sales, by fiscal year.
Balance-sheet value is the reporting company's own listed holdings (its largest holding subsidiary's where marked), carried at market value; the percentage divides it by consolidated net assets in the same annual report.
| Fiscal year end | Holdings (issuers) | Balance-sheet value | % of consolidated net assets | Issues cut | Sale proceeds | Filing |
|---|---|---|---|---|---|---|
| 31 Dec 2025 | 16 | ¥7.84bn | 6.65% | 2 | ¥51m | Filed — filing S100XS06 |
| Fiscal year end | Holdings (issuers) | Balance-sheet value | % of consolidated net assets | Issues cut | Sale proceeds | Filing |
|---|---|---|---|---|---|---|
| 31 Dec 2024 | 16 | ¥5.96bn | 5.16% | 2 | ¥8.18bn | Filed — filing S100VFAX |
| 31 Dec 2023 | 18 | ¥13.8bn | 12.46% | 4 | ¥891m | Filed — filing S100T30E |
| 31 Dec 2022 | 22 | ¥11bn | 9.88% | 1 | ¥2.08bn | Filed — filing S100QELG |
| 31 Dec 2021 | 22 | ¥14.7bn | 14.94% | 3 | ¥335m | Filed — filing S100NP0E |
| 31 Dec 2020 | 25 | ¥16.1bn | 19.60% | 2 | ¥6.26bn | Filed — filing S100KZ5J |
Current holdings disclosed by tracked funds.
Held by 22 tracked funds; largest weight 0.03%. Holdings as of 31 Jul 2026–13 Nov 2026.
| Fund | NAV weight |
|---|---|
| NZAM ETF TOPIX | 0.00% |
| iShares Core TOPIX ETF | 0.00% |
| SMT ETF Carbon Efficient Index Japan Equity | 0.00% |
| NEXT FUNDS TOPIX Exchange Traded Fund | 0.00% |
| Listed Index Fund TOPIX **** | 0.00% |
| MAXIS TOPIX ETF | 0.00% |
| iFreeETF TOPIX (Yearly Dividend Type) **** | 0.00% |
| One ETF TOPIX | 0.00% |
| iFreeETF TOPIX (Quarterly Dividend Type) **** | 0.00% |
| SMDAM TOPIX ETF | 0.00% |
| Nissay ETF TOPIX (Quarterly settlement type) | 0.00% |
| NZAM ETF S&P/JPX Carbon Efficient Index | 0.00% |